In the news
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 8, 2021Healio GastroenterologyRegardless of experience level, endoscopists reported successful use of the first single-use duodenoscope for endoscopic retrograde cholangiopancreatography, Adam Slivka, MD, PhD, University of Pittsburgh, told Healio Gastroenterology.
-
May 25, 2021Medical Tubing + ExtrusionBoston Scientific today said it received CE mark approval for its Exalt Model B single-use bronchoscope. The company designed the device for bedside procedures in the intensive care unit, operating room and bronchoscopy suite.
-
May 18, 2021MedscapeBoston Scientific’s implant led to stroke rates 77% lower than typically expected among older people with atrial fibrillation and high risk scores.
-
May 17, 2021DeviceTalksJeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing.
-

-
Mar 26, 2021MedTechDiveThe clinical trial found a correlation between survival and radiation absorbed by the tumor, giving Boston Scientific data to make the case for using the recently approved device.
-
Mar 18, 2021ONCLiveThe FDA has approved TheraSphere™ Yttrium-90 (Y-90) Glass Microspheres for the treatment of patients with hepatocellular carcinoma.
-
Mar 3, 2021FierceBioTechBoston Scientific aims to acquire Lumenis’ global surgical laser business, through a $1.07 billion deal that will incorporate its systems for ear, nose and throat procedures and its Moses laser treatment for breaking apart kidney stones.
-
Jan 25, 2021MedTech InsightBoston Scientific is making moves to strengthen its line of rhythm management diagnostics with the acquisition of privately held Preventice Solutions, Inc., a company that not only offers remote monitoring for cardiac issues, but also integrates deep learning algorithms and artificial intelligence to generate data used in diagnosis.
-
Jan 22, 2021MassDeviceBoston Scientific’s Vercise Genus deep brain stimulation (DBS) system portfolio is approved for conditional use in a magnetic resonance imaging (MRI) environment. It features a family of Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators capable of powering Cartesia directional leads to offer symptom relief for those suffering from Parkinson’s disease.